Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

611 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The use of proliferation signal inhibitors in the prevention and treatment of allograft vasculopathy in heart transplantation.
Delgado JF, Manito N, Segovia J, Almenar L, Arizón JM, Campreciós M, Crespo-Leiro MG, Díaz B, González-Vílchez F, Mirabet S, Palomo J, Roig E, de la Torre JM. Delgado JF, et al. Among authors: segovia j. Transplant Rev (Orlando). 2009 Apr;23(2):69-79. doi: 10.1016/j.trre.2009.01.002. Transplant Rev (Orlando). 2009. PMID: 19298938 Review.
Similar efficacy and safety of enteric-coated mycophenolate sodium (EC-MPS, myfortic) compared with mycophenolate mofetil (MMF) in de novo heart transplant recipients: results of a 12-month, single-blind, randomized, parallel-group, multicenter study.
Kobashigawa JA, Renlund DG, Gerosa G, Almenar L, Eisen HJ, Keogh AM, Lehmkuhl HB, Livi U, Ross H, Segovia J, Yonan N; ERL2401 Heart Study Investigators. Kobashigawa JA, et al. Among authors: segovia j. J Heart Lung Transplant. 2006 Aug;25(8):935-41. doi: 10.1016/j.healun.2006.04.005. Epub 2006 Jun 27. J Heart Lung Transplant. 2006. PMID: 16890114 Clinical Trial.
Impact of dose reductions on efficacy outcome in heart transplant patients receiving enteric-coated mycophenolate sodium or mycophenolate mofetil at 12 months post-transplantation.
Segovia J, Gerosa G, Almenar L, Livi U, Viganò M, Arizón JM, Yonan N, Di Salvo TG, Renlund DG, Kobashigawa JA; ERL 2401 Study Group. Segovia J, et al. Clin Transplant. 2008 Nov-Dec;22(6):809-14. doi: 10.1111/j.1399-0012.2008.00887.x. Epub 2008 Aug 12. Clin Transplant. 2008. PMID: 18702660 Clinical Trial.
[Current status of heart transplantation in Spain].
Almenar L, Delgado J, Crespo M, Segovia J. Almenar L, et al. Among authors: segovia j. Rev Esp Cardiol. 2010 Jan;63 Suppl 1:132-49. doi: 10.1016/s0300-8932(10)70146-9. Rev Esp Cardiol. 2010. PMID: 20223185 Free article. Spanish.
Risk factors associated with moderate-to-severe renal dysfunction among heart transplant patients: results from the CAPRI study.
Delgado JF, Crespo-Leiro MG, Gómez-Sánchez MA, Paniagua MJ, González-Vílchez F, Vázquez de Prada JA, Fernández-Yáñez J, Pascual D, Almenar L, Martínez-Dolz L, Díaz B, Roig E, Segovia J, Arizón JM, Garrido I, Blasco T, López J, Brossa V, Manito N, Muñiz J. Delgado JF, et al. Among authors: segovia j. Clin Transplant. 2010 Sep-Oct;24(5):E194-200. doi: 10.1111/j.1399-0012.2010.01249.x. Clin Transplant. 2010. PMID: 20597926
Clinical recommendations for the use of everolimus in heart transplantation.
Manito N, Delgado JF, Crespo-Leiro MG, González-Vílchez F, Almenar L, Arizón JM, Díaz B, Fernández-Yáñez J, Mirabet S, Palomo J, Rodríguez Lambert JL, Roig E, Segovia J. Manito N, et al. Among authors: segovia j. Transplant Rev (Orlando). 2010 Jul;24(3):129-42. doi: 10.1016/j.trre.2010.01.005. Transplant Rev (Orlando). 2010. PMID: 20619801 Review.
Spanish Heart Transplantation Registry. 21st Official Report of the Spanish Society of Cardiology Working Group on Heart Failure and Heart Transplantation (1984-2009).
Almenar L, Segovia J, Crespo-Leiro MG, Palomo J, Arizón JM, González-Vílchez F, Delgado J; Spanish Heart Transplantation Teams. Almenar L, et al. Among authors: segovia j. Rev Esp Cardiol. 2010 Nov;63(11):1317-28. doi: 10.1016/s1885-5857(10)70256-5. Rev Esp Cardiol. 2010. PMID: 21070727 Free article. English, Spanish.
Report from a consensus conference on antibody-mediated rejection in heart transplantation.
Kobashigawa J, Crespo-Leiro MG, Ensminger SM, Reichenspurner H, Angelini A, Berry G, Burke M, Czer L, Hiemann N, Kfoury AG, Mancini D, Mohacsi P, Patel J, Pereira N, Platt JL, Reed EF, Reinsmoen N, Rodriguez ER, Rose ML, Russell SD, Starling R, Suciu-Foca N, Tallaj J, Taylor DO, Van Bakel A, West L, Zeevi A, Zuckermann A; Consensus Conference Participants. Kobashigawa J, et al. J Heart Lung Transplant. 2011 Mar;30(3):252-69. doi: 10.1016/j.healun.2010.11.003. J Heart Lung Transplant. 2011. PMID: 21300295 Free PMC article.
611 results